The global cystoscope market size is anticipated to reach USD 2.17 billion by 2030 and is anticipated to expand at a CAGR of 9.99% during the forecast period, according to a new report by Grand View Research, Inc. The cystoscope market is driven by numerous factors such as technological advancements, rising number of clinical trials and growing competition among the industry players.
The increasing focus on research activities and clinical studies using cystoscopes in wide applications is anticipated to propel the market growth in the coming years. For instance, in December 2024, Medtecx Co Ltd. sponsored a clinical trial involving 126 study participants to evaluate the safety and efficacy of the water vapor thermal therapy system for treating benign prostatic hyperplasia.
Moreover, in February 2023, the Centre Hospitalier Universitaire Vaudois sponsored a clinical study to demonstrate that using a flexible cystoscope provides the same quality of urine collection for analysis as using an intermittent bladder catheter while being less uncomfortable for the patient. The study enrolled approximately 414 participants . Therefore, the growing utilization of cystoscopes in various clinical trials and studies is expected to drive market growth in the coming years.
Furthermore, the growing demand for cystoscopy procedures, driven by the increasing prevalence of urological disorders, is expected to boost market growth. A significant number of cystoscopy procedures are being conducted in both hospitals and outpatient settings. For instance, data from the MD Anderson Cancer Center published in July 2024 indicates that approximately 16 cystoscopies are performed daily, totaling over 4,000 annually. This high volume of diagnostic procedures is projected to stimulate cystoscope market growth in the coming years.
Request a free sample copy or view report summary: Cystoscope Market Report
The flexible cystoscope segment dominated the market and is expected to register the fastest CAGR of 10.93% during the forecast period, owing to novel product launches by industry key players to expand their product portfolio.
The video cystoscope segment dominated the market and is expected to register the fastest CAGR of 10.73% during the forecast period. The increasing regulatory approvals for advanced cystoscopes, such as video cystoscopes, are supporting the segment's growth.
The urology segment dominated the market and is expected to register the fastest CAGR of 10.56% in the coming years. The increasing prevalence of urological conditions such as urinary incontinence, urinary tract infections, and bladder cancer is anticipated to drive the segment's growth.
The hospital segment dominated the market and accounted for the revenue share of 40.64% in 2024. On the other hand, the ambulatory surgery center segment is expected to grow with the highest CAGR in the coming years.
For the purpose of this report, Grand View Research has segmented the cystoscope market on the basis of product, type, end-use, application, and region:
Cystoscope Product Outlook (Revenue, USD Million, 2018 - 2030)
Flexible Cystoscopes
Rigid Cystoscopes
Cystoscope Application Outlook (Revenue, USD Million, 2018 - 2030)
Urology
Gynecology
Cystoscope End Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Diagnostic Imaging Centers
Ambulatory Surgery Centers
Others
Cystoscope Type Outlook (Revenue, USD Million, 2018 - 2030)
Video Cystoscopes
Fiberoptic Cystoscopes
Cystoscope Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of key players in the Cystoscope market
Olympus Corporation
Boston Scientific Corporation or its affiliates.
Ambu Inc.
KARL STORZ
Advin Health Care
Intuitive Surgical (SCHÖLLY FIBEROPTIC GMBH)
Stryker
UroViu Corporation
NeoScope Inc.
OTU Medical
HOYA Corporation (Pentax Medical)
"The quality of research they have done for us has been excellent..."